Assignee
TEMPUS LABS INC
US·48 granted patents·59 pending applications·317 citations·filing 2019–2023
Top patents by PatentIndex Score
107 records- 0196US11532397B2Mobile supplementation, extraction, and analysis of health recordsTEMPUS LABS INC·Filed 2021·Granted Dec 20, 2022·10 cites·30 claims
- 0296US11145416B1Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Oct 12, 2021·29 cites·80 claims
- 0395US11848107B2Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Dec 19, 2023·5 cites·29 claims
- 0495US11594222B2Collaborative artificial intelligence method and systemTEMPUS LABS INC·Filed 2021·Granted Feb 28, 2023·3 cites·30 claims
- 0595US11244763B2Predicting likelihood and site of metastasis from patient recordsTEMPUS LABS INC·Filed 2021·Granted Feb 8, 2022·5 cites·76 claims
- 0695US10957041B2Determining biomarkers from histopathology slide imagesTEMPUS LABS INC·Filed 2020·Granted Mar 23, 2021·42 cites·30 claims
- 0794US11682098B2Determining biomarkers from histopathology slide imagesTEMPUS LABS INC·Filed 2021·Granted Jun 20, 2023·6 cites·28 claims
- 0894US11610307B2Determining biomarkers from histopathology slide imagesTEMPUS LABS INC·Filed 2021·Granted Mar 21, 2023·7 cites·30 claims
- 0994US11348661B2Predicting total nucleic acid yield and dissection boundaries for histology slidesTEMPUS LABS INC·Filed 2020·Granted May 31, 2022·11 cites·29 claims
- 1094US11348239B2Predicting total nucleic acid yield and dissection boundaries for histology slidesTEMPUS LABS INC·Filed 2020·Granted May 31, 2022·11 cites·27 claims
- 1194US11263748B2Determining biomarkers from histopathology slide imagesTEMPUS LABS INC·Filed 2021·Granted Mar 1, 2022·8 cites·30 claims
- 1294US11211144B2Methods and systems for refining copy number variation in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Granted Dec 28, 2021·6 cites·100 claims
- 1394US11037685B2Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2020·Granted Jun 15, 2021·5 cites·30 claims
- 1493US11699507B2Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2021·Granted Jul 11, 2023·3 cites·27 claims
- 1593US11561178B2Artificial fluorescent image systems and methodsTEMPUS LABS INC·Filed 2021·Granted Jan 24, 2023·8 cites·30 claims
- 1693US11211147B2Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencingTEMPUS LABS INC·Filed 2021·Granted Dec 28, 2021·8 cites·81 claims
- 1793US11043304B2Systems and methods for using sequencing data for pathogen detectionTEMPUS LABS INC·Filed 2020·Granted Jun 22, 2021·15 cites·13 claims
- 1892US11935152B2Determining biomarkers from histopathology slide imagesTEMPUS LABS INC·Filed 2023·Granted Mar 19, 2024·2 cites·19 claims
- 1992US11475981B2Methods and systems for dynamic variant thresholding in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Granted Oct 18, 2022·4 cites·29 claims
- 2092US11415571B2Large scale organoid analysisTEMPUS LABS INC·Filed 2020·Granted Aug 16, 2022·9 cites·27 claims
- 2192US11348240B2Predicting total nucleic acid yield and dissection boundaries for histology slidesTEMPUS LABS INC·Filed 2020·Granted May 31, 2022·5 cites·27 claims
- 2292US11081210B2Detection of human leukocyte antigen loss of heterozygosityTEMPUS LABS INC·Filed 2020·Granted Aug 3, 2021·13 cites·30 claims
- 2392US11043283B1Systems and methods for automating RNA expression calls in a cancer prediction pipelineTEMPUS LABS INC·Filed 2020·Granted Jun 22, 2021·12 cites·54 claims
- 2491US11756688B2ECG-based cardiovascular disease detection systems and related methodsTEMPUS LABS INC·Filed 2022·Granted Sep 12, 2023·2 cites·29 claims
- 2590US11657921B2Artificial intelligence based cardiac event predictor systems and methodsTEMPUS LABS INC·Filed 2022·Granted May 23, 2023·5 cites·29 claims
- 2690US11527323B2Systems and methods for multi-label cancer classificationTEMPUS LABS INC·Filed 2020·Granted Dec 13, 2022·15 cites·8 claims
- 2790US10991097B2Artificial intelligence segmentation of tissue imagesTEMPUS LABS INC·Filed 2019·Granted Apr 27, 2021·15 cites·18 claims
- 2890US10975445B2Integrated machine-learning framework to estimate homologous recombination deficiencyTEMPUS LABS INC·Filed 2020·Granted Apr 13, 2021·12 cites·31 claims
- 2989US11414700B2TCR/BCR profiling using enrichment with pools of capture probesTEMPUS LABS INC·Filed 2021·Granted Aug 16, 2022·5 cites·20 claims
- 3088US11875903B2Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2021·Granted Jan 16, 2024·8 cites·19 claims
- 3187US11727674B2Systems and methods for generating histology image training datasets for machine learning modelsTEMPUS LABS INC·Filed 2021·Granted Aug 15, 2023·2 cites·30 claims
- 3287US11041200B2Systems and methods for next generation sequencing uniform probe designTEMPUS LABS INC·Filed 2020·Granted Jun 22, 2021·2 cites·28 claims
- 3385US11309090B2Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2021·Granted Apr 19, 2022·1 cites·30 claims
- 3485US11164655B2Systems and methods for predicting homologous recombination deficiency status of a specimenTEMPUS LABS INC·Filed 2020·Granted Nov 2, 2021·2 cites·26 claims
- 3584US11869668B2Artificial intelligence based cardiac event predictor systems and methodsTEMPUS LABS INC·Filed 2022·Granted Jan 9, 2024·1 cites·30 claims
- 3683US11769572B2Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2020·Granted Sep 26, 2023·1 cites·31 claims
- 3782US11741365B2Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide imagesTEMPUS LABS INC·Filed 2019·Granted Aug 29, 2023·5 cites·15 claims
- 3882US11629385B2Tumor organoid culture compositions, systems, and methodsTEMPUS LABS INC·Filed 2019·Granted Apr 18, 2023·5 cites·20 claims
- 3982US11475978B2Detection of human leukocyte antigen loss of heterozygosityTEMPUS LABS INC·Filed 2021·Granted Oct 18, 2022·1 cites·30 claims
- 4078US11742064B2Automated quality assurance testing of structured clinical dataTEMPUS LABS INC·Filed 2019·Granted Aug 29, 2023·4 cites·30 claims
- 4176US11715565B2Evaluating effect of event on condition using propensity scoringTEMPUS LABS INC·Filed 2019·Granted Aug 1, 2023·2 cites·45 claims
- 4276US11189029B23D radiomic platform for imaging biomarker developmentTEMPUS LABS INC·Filed 2019·Granted Nov 30, 2021·2 cites·31 claims
- 4375US2023343464A1ECG-Based Cardiovascular Disease Detection Systems and Related MethodsTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 4475US2024087747A1Method and process for predicting and analyzing patient cohort response, progression, and survivalTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 4573US2023386643A1Data-based mental disorder research and treatment systems and methodsTEMPUS LABS INC·Filed 2023·Application pending·0 cites
- 4671US11651442B2Mobile supplementation, extraction, and analysis of health recordsTEMPUS LABS INC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 4771US11613783B2Systems and methods for detecting multi-molecule biomarkersTEMPUS LABS INC·Filed 2021·Granted Mar 28, 2023·0 cites·7 claims
- 4870US2022336046A1Methods and systems for refining copy number variation in a liquid biopsy assayTEMPUS LABS INC·Filed 2021·Application pending·0 cites
- 4970US2022367006A1Methods and systems for dynamic variant thresholding in a liquid biopsy assayTEMPUS LABS INC·Filed 2022·Application pending·0 cites
- 5069US11682481B2Data-based mental disorder research and treatment systems and methodsTEMPUS LABS INC·Filed 2021·Granted Jun 20, 2023·0 cites·20 claims
Showing the top 50 of 107 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →